Lazure Scientific, Inc.

We have developed a revolutionary device to treat prostate cancer without life altering side effects (currently in human clinical trials).

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Issaquah, WA, USA
  • Currency USD
  • Founded December 2006
  • Employees 2
  • Website LazureScientific.com

Company Summary

Current prostate cancer treatments (surgery, radiation) result in extremely high rates of urinary incontinence and sexual side effects. Prostate cancer is the most common cancer in men with over 240K men diagnosed and over 30K deaths annually in the USA. A whole gland treatment, such as ours, without side effects would provide for an extremely significant competitive advantage over current treatments and would provide men a better option.

Team

  • Charles Hill
    President and CEO

    24+ years of business and executive management experience. Formerly with KPMG (CPA) and Pistol Creek Company (a privately held investment company). Designed and oversees all aspects of preclinical testing as well as human clinical trials. Selected, engaged, and oversees all regulatory and clinical trial management consultants. Develop and manage patent strategies and counsel. Work closely with engineering/design device development team.

  • Joshua Hockett
    Chief Technology Officer

    10+ years of engineering and system design experience. Formerly with Synapse Product Development. Expert mechanical and electrical engineering specialist with extensive medical device development experience. Lead architect/designer for all preclinical and clinical devices. Oversees and engages all external engineering/design teams. Participates in physician and hospital staff training at clinical trial site locations.

  • Dr. Paul Lange
    Chief Medical Advisor

    Dr. Lange graduated from Washington University Medical School and received his general surgery and urology training at the University of Rochester, Duke University and the University of Minnesota. In 1988, Dr. Lange moved to the University of Washington as Professor and Chairman of the Department of Urology, a position held for 19 years. Dr. Lange is extensively published and was formerly on the New England Journal of Medicine editorial board.

Advisors

  • Daren Nitz - General, Mike Rosato (Wilson Sonsini) - Patent
    Lawyer
    Unconfirmed
    Rick Cooley - Clark Nuber PS
    Accountant
    Unconfirmed

Previous Investors

  • High Net Worth Individuals Only
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free